Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012).
Chen H, Maimaitiaili A, Liu Z, Ling R, Zhao Y, Yang H, Liu Y, Liu K, Zhang J, Mao D, Yu Z, Liu Y, Fu P, Wang J, Jiang H, Zhao Z, Tian X, Cao Z, Wu K, Song A, Jin F, He J, Fan Z, Zhang H. Chen H, et al. Ther Adv Med Oncol. 2023 Feb 28;15:17588359231156146. doi: 10.1177/17588359231156146. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36891484 Free PMC article.
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy.
Maimaitiaili A, Chen H, Xie P, Liu Z, Ling R, Zhao Y, Yang H, Liu Y, Liu K, Zhang J, Mao D, Yu Z, Liu Y, Fu P, Wang J, Jiang H, Zhao Z, Tian X, Cao Z, Wu K, Song A, Jin F, He J, Fan Z, Zhang H. Maimaitiaili A, et al. J Cancer Res Clin Oncol. 2023 Sep;149(11):8769-8778. doi: 10.1007/s00432-023-04817-9. Epub 2023 May 2. J Cancer Res Clin Oncol. 2023. PMID: 37129606
Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study.
Ma L, Gao P, Liu Z, Jiao D, Ling R, Xiao J, Zhao Y, Wang Y, Yang H, Liu Y, Liu K, Zhang J, Li G, Mao D, Deng Y, He J, Amina M, Yu Z, Fei W, Liu Y, Fu P, Yao M, Wang J, Zhu L, Jiang H, Zhao Z, Tian X, Cao Z, Ma X, Wu K, Fu S, Song A, Wang Y, Feng J, Fan Z. Ma L, et al. Chin Med J (Engl). 2023 Oct 25. doi: 10.1097/CM9.0000000000002849. Online ahead of print. Chin Med J (Engl). 2023. PMID: 37882089 No abstract available.
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
Guo X, Zhang J, Gong X, Wang J, Dai H, Jiao D, Ling R, Zhao Y, Yang H, Liu Y, Liu K, Zhang J, Mao D, He J, Yu Z, Liu Y, Fu P, Wang J, Jiang H, Zhao Z, Tian X, Cao Z, Wu K, Song A, Jin F, Fan Z, Liu Z. Guo X, et al. Breast. 2024 Feb;73:103671. doi: 10.1016/j.breast.2024.103671. Epub 2024 Jan 5. Breast. 2024. PMID: 38277714 Free PMC article.
Withaferin-A Inhibits Growth of Drug-Resistant Breast Carcinoma by Inducing Apoptosis and Autophagy, Endogenous Reactive Oxygen Species (ROS) Production, and Inhibition of Cell Migration and Nuclear Factor kappa B (Nf-κB)/Mammalian Target of Rapamycin (m-TOR) Signalling Pathway.
Liu X, Li Y, Ma Q, Wang Y, Song AL. Liu X, et al. Among authors: song al. Med Sci Monit. 2019 Sep 12;25:6855-6863. doi: 10.12659/MSM.916931. Med Sci Monit. 2019. PMID: 31512681 Free PMC article. Retracted.
59 results